Publication date: Sep 10, 2021 This phase I trial tests the safety, side effects, and best dose of IACS-6274 with or without pembrolizumab in treating patients with solid tumors that ... Read more

Publication date: Sep 10, 2021 This phase I trial tests the safety, side effects, and best dose of IACS-6274 with or without pembrolizumab in treating patients with solid tumors that ... Read more

Publication date: Sep 10, 2021 This phase I trial tests the safety, side effects, and best dose of IACS-6274 with or without pembrolizumab in treating patients with solid tumors that ... Read more

Publication date: Sep 10, 2021 This phase I trial tests the safety, side effects, and best dose of IACS-6274 with or without pembrolizumab in treating patients with solid tumors that ... Read more

Publication date: Sep 12, 2021 They listed 8 ongoing trials, ranging from phase 1 to phase 3, of treatment options, many of which are still recruiting patients. First line treatment ... Read more

Publication date: Sep 12, 2021 They listed 8 ongoing trials, ranging from phase 1 to phase 3, of treatment options, many of which are still recruiting patients. First line treatment ... Read more

Publication date: Sep 12, 2021 They listed 8 ongoing trials, ranging from phase 1 to phase 3, of treatment options, many of which are still recruiting patients. First line treatment ... Read more

Publication date: Sep 12, 2021 They listed 8 ongoing trials, ranging from phase 1 to phase 3, of treatment options, many of which are still recruiting patients. First line treatment ... Read more

Publication date: Sep 10, 2021 Since its foundation, OncoBeta has concentrated its efforts on the development, regulatory approval(s) and commercialization of the epidermal radioisotope therapy Rhenium-SCT (Skin Cancer Therapy), targeting ... Read more

Publication date: Sep 07, 2021 Malignant melanoma is a common skin cancer that is mostly curable before metastasis, where melanoma growths spawn in organs away from the original site. Melanoma ... Read more